Bio-Techne Corp reports results for the quarter ended December 31 - Earnings Summary

• Bio-Techne Corp TECH.OQ reported quarterly adjusted earnings of 42 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 40 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 39 cents per share. Wall Street expected results to range from 36 cents to 40 cents per share.

• Revenue rose 8.3% to $295.18 million from a year ago; analysts expected $285.74 million.

• Bio-Techne Corp's reported EPS for the quarter was 22 cents​.

• The company reported quarterly net income of $34.89 million.

• Bio-Techne Corp shares had risen by 0.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Bio-Techne Corp is $86.42

This summary was machine generated from LSEG data February 5 at 03:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)